Skip to main content
Log in

Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma

  • Published:
Obesity Surgery Aims and scope Submit manuscript

Non-alcoholic fatty liver disease (NAFLD) is characterized by an excessive accumulation of fatty acids and triglycerides within the cytoplasm of the hepatocytes of non-alcohol users. The natural history varies according to the initial histological diagnosis. A current consideration is that cryptogenic cirrhosis may be representative of a late stage of non-alcoholic steatohepatitis (NASH), which has lost its features of necroinflammatory activity and steatosis in up to 80% of patients. Since NASH is able to progress to cirrhosis, hepatocellular carcinoma (HCC) development may be an end-stage of this disease. We report below two clinical cases of patients diagnosed with NASH who developed HCC. The relationship between NAFLD and HCC is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cuadrado, A., Orive, A., García-Suárez, C. et al. Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma. OBES SURG 15, 442–446 (2005). https://doi.org/10.1381/0960892053576596

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1381/0960892053576596

Navigation